Related Experiment Video

Updated: May 14, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Network insights on oxaliplatin anti-cancer mechanisms

Osama M Alian1, Asfar S Azmi, Ramzi M Mohammad

  • 1Department of Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R, HWCRC, Room 732, Detroit, MI, 48201, USA. mohammar@karmanos.org.

Clinical and Translational Medicine
|February 2, 2013
PubMed

Insights

Oxaliplatin chemotherapy shows modest survival gains but acts non-targeted. New network models reveal its role in tumorigenesis and resistance, suggesting improved drug design.

Area of Science:

  • Oncology
  • Molecular Biology
  • Systems Biology

Background:

  • Oxaliplatin is a key chemotherapy agent improving survival in various cancers.
  • Its non-targeted action and precise mechanisms of efficacy remain unclear.
  • Platinum-protein adducts are more abundant than DNA adducts, indicating unknown functions.

Purpose of the Study:

  • To critically review oxaliplatin efficacy using network modeling.
  • To propose an enhanced network-based model for improved therapeutic outcomes.
  • To elucidate the complex signaling networks influenced by oxaliplatin.

Main Methods:

  • Utilized preliminary network modeling of high-throughput data.
  • Analyzed oxaliplatin's impact on DNA replication and cellular pathways.
  • Investigated competing signaling networks to explain treatment resistance and cancer progression.

Main Results:

  • Confirmed oxaliplatin's role in DNA replication interruption.
  • Uncovered oxaliplatin's involvement in initiating or intensifying tumorigenesis pathways.
  • Identified competing signaling networks explaining chemoresistance, cancer stem cell survival, invasiveness, and metastasis.

Conclusions:

  • Oxaliplatin's effects extend beyond DNA repair, influencing complex signaling networks.
  • Network modeling provides a novel framework for understanding oxaliplatin's multifaceted roles.
  • Understanding these networks is crucial for rational drug design and enhancing oxaliplatin efficacy.

More Related Videos

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...